Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
about
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literatureOverexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patientsMetalloproteinases and tissue inhibitors of metalloproteinases.The relationship between prognostic and predictive factors in the management of breast cancer.Proteolysis in human breast cancer.Expression of proteinases and inhibitors in human breast cancer progression and survival.Collagenase expression and activity in the stromal cells from giant cell tumour of bone.Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.Hyaluronidase activity in gynaecological cancer tissues with different metastatic forms.Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluationExpression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast.Dynamics of metalloproteinase-2 and -9, TGF-beta, and uPA activities during normoxic vs. hyperoxic alveolarization.Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.High levels of TIMP-2 correlate with adverse prognosis in breast cancer.Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients.
P2860
Q24652514-263862C7-E649-42EE-AD16-E4EA5265E5FEQ28366039-A394064D-00F8-4111-95CB-D64157EAB464Q33538435-40890E6A-0FFA-42F2-9B4A-0C179A55FE92Q33538455-C45FFA64-AF4F-48DA-B755-DC4EA8C0EC99Q33918458-46F263AF-DDC7-4FF2-9630-0C298DB2E5FAQ33919059-8698FFE4-2E16-4F4E-88C3-969692EBDB87Q33952332-DC989B6D-10C1-42DD-9A34-A9F476AF4A08Q36135756-3474E71A-C064-4C7E-920E-506BA92A71A8Q36421987-F158F686-F340-4688-AAFE-5CC520D761C1Q36611620-CAA47D32-B60C-4E57-A61A-3C7C53F64F29Q36612227-7E717B3B-BF88-41B9-84D5-8B02E561A3C5Q37206817-DE4A7CDC-1F00-4D31-9F48-C4D45FCA3DF0Q46697459-5B447E19-369A-45D5-91FE-E61F6AA08138Q46788870-1C262730-AD86-4017-BCFD-2E6D0C63719CQ51155840-C82960A0-9A2C-41C3-BDDA-90970CA296D1Q52141709-CD18EE24-45AC-46D1-9418-580DA5DEA8F5Q55475255-5DA17FD9-EF61-485A-A618-347093E87318
P2860
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
@en
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
@nl
type
label
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
@en
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
@nl
prefLabel
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
@en
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
@nl
P2093
P2860
P356
P1476
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer
@en
P2093
E McDermott
H Tschesche
J J Fennelly
N O'Higgins
P2860
P2888
P304
P356
10.1038/BJC.1995.197
P407
P577
1995-05-01T00:00:00Z